Global Wound Care Biologics Market Report

List of Tables

The global demand for Wound Care Biologics Market is presumed to reach the market size of nearly USD 4.06 MN by 2030 from USD 2.63 MN in 2022 with a CAGR of 6.4% under the study period 2023 - 2030.

Wound care biologics are bioengineered products used to treat non-healing lower extremity wounds. Every stage of wound management is covered under wound biologics. This includes determining the wound type, specifying elements that affect wound healing, and applying the appropriate wound management therapy. Wound biologics cover each step of wound care. This entails identifying the type of wound, pinpointing factors that influence wound healing, and implementing the appropriate wound management therapy. Once the wound has been evaluated, and all requirements have been examined, the treatment facility can decide on the best treatment options.

MARKET DYNAMICS:

The prevalence of burn injuries is rising, and there are more car accidents and the traumatic injuries they cause. These trends are driving the market expansion. The main barriers to the expansion of this market, however, are the high price of biologic wound care treatments and the danger of skin substitute failure. Nonetheless, as early treatment of diabetic ulcers can prevent serious complications like infection, hospitalisation, and amputation, demand for wound care biologic products is anticipated to rise dramatically. Furthermore, the commercially available skin substitutes offer clinical and scientific proof of efficacy in wound healing, further propelling the market forward.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of wound care biologics. The growth and trends of wound care biologics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the wound care biologics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Biological Skin Substitutes (Human Donor Tissue-Derived Products, Acellular Animal-Derived Products, Biosynthetic Products)
Topical Agents
Others

By Wound Type

Ulcers(Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Other Ulcers)
Surgical & Traumatic Wounds
Burns
Others Wound Type

By End User

Hospitals
Ambulatory Surgery Centers
Burn Care Centers & Wound Clinics and Home Settings

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Wound Care Biologics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the wound care biologics market include Smith & Nephew plc (UK), Organogenesis Inc. (US), MIMEDX (US), Integra LifeSciences (US), and Stryker Corporation (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11218730

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . WOUND CARE BIOLOGICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Wound Type
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL WOUND CARE BIOLOGICS MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Biological Skin Substitutes (Human Donor Tissue-derived Products, Acellular Animal-derived Products, Biosynthetic Products) Historic and Forecast Sales by Regions
6.5 Topical Agents Historic and Forecast Sales by Regions
6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL WOUND CARE BIOLOGICS MARKET ANALYSIS BY WOUND TYPE

7.1 Overview by Wound Type
7.2 Historical and Forecast Data
7.3 Analysis by Wound Type
7.4 Ulcers(Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Other Ulcers) Historic and Forecast Sales by Regions
7.5 Surgical & Traumatic Wounds Historic and Forecast Sales by Regions
7.6 Burns Historic and Forecast Sales by Regions
7.7 Other Wound Care Historic and Forecast Sales by Regions

8 . GLOBAL WOUND CARE BIOLOGICS MARKET SALES ANALYSIS BY END USER

8.1 Overview by End User
8.2 Historical and Forecast Data
8.3 Analysis by End User
8.4 Hospitals Historic and Forecast Sales by Regions
8.5 Ambulatory Surgery Centers Historic and Forecast Sales by Regions
8.6 Burn Care Centers & Wound Clinics and Home Settings Historic and Forecast Sales by Regions

9 . GLOBAL WOUND CARE BIOLOGICS MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE WOUND CARE BIOLOGICS COMPANIES

10.1. Wound Care Biologics Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF WOUND CARE BIOLOGICS INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Smith & Nephew plc (UK)
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Organogenesis Inc. (US)
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. MIMEDX (US)
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Integra LifeSciences (US)
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Stryker Corporation (US)
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies